Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 204

1.

Harnessing cells to deliver nanoparticle drugs to treat cancer.

Singh B, Mitragotri S.

Biotechnol Adv. 2019 Jan 10. pii: S0734-9750(19)30006-0. doi: 10.1016/j.biotechadv.2019.01.006. [Epub ahead of print] Review.

PMID:
30639928
2.

Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers.

Zhao Z, Ukidve A, Krishnan V, Mitragotri S.

Adv Drug Deliv Rev. 2019 Jan 10. pii: S0169-409X(19)30002-X. doi: 10.1016/j.addr.2019.01.002. [Epub ahead of print]

PMID:
30639257
3.

Shape-based separation of synthetic microparticles.

Mage PL, Csordas AT, Brown T, Klinger D, Eisenstein M, Mitragotri S, Hawker C, Soh HT.

Nat Mater. 2019 Jan;18(1):82-89. doi: 10.1038/s41563-018-0244-9. Epub 2018 Dec 10.

PMID:
30542094
4.

Treating Tumors at Low Drug Doses Using an Aptamer-Peptide Synergistic Drug Conjugate.

Pusuluri A, Krishnan V, Lensch V, Sarode A, Bunyan E, Vogus DR, Menegatti S, Soh HT, Mitragotri S.

Angew Chem Int Ed Engl. 2018 Dec 11. doi: 10.1002/anie.201812650. [Epub ahead of print]

PMID:
30537284
5.

Non-invasive delivery strategies for biologics.

Anselmo AC, Gokarn Y, Mitragotri S.

Nat Rev Drug Discov. 2018 Nov 30. doi: 10.1038/nrd.2018.183. [Epub ahead of print] Review.

PMID:
30498202
6.

Reply to Rogers and Gurau: Definitions of ionic liquids and deep eutectic solvents.

Banerjee A, Ibsen K, Brown T, Chen R, Agatemor C, Mitragotri S.

Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11000-E11001. doi: 10.1073/pnas.1815526115. Epub 2018 Nov 6. No abstract available.

PMID:
30401740
7.

Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.

Vaidya B, Parvathaneni V, Kulkarni NS, Shukla SK, Damon JK, Sarode A, Kanabar D, Garcia JV, Mitragotri S, Muth A, Gupta V.

Int J Biol Macromol. 2019 Feb 1;122:338-347. doi: 10.1016/j.ijbiomac.2018.10.181. Epub 2018 Oct 26.

PMID:
30401652
8.

Engineering clinical translation-Introduction to Special Issue Dedicated to 2017 Bioengineering and Translational Medicine Conference.

Kannan RM, Mitragotri S.

Bioeng Transl Med. 2018 Oct 8;3(3):185. doi: 10.1002/btm2.10115. eCollection 2018 Sep. No abstract available.

9.

Influence of particle size and shape on their margination and wall-adhesion: implications in drug delivery vehicle design across nano-to-micro scale.

Cooley M, Sarode A, Hoore M, Fedosov DA, Mitragotri S, Sen Gupta A.

Nanoscale. 2018 Aug 16;10(32):15350-15364. doi: 10.1039/c8nr04042g.

PMID:
30080212
10.

Detachment of ligands from nanoparticle surface under flow and endothelial cell contact: Assessment using microfluidic devices.

Jarvis M, Arnold M, Ott J, Krishnan V, Pant K, Prabhakarpandian B, Mitragotri S.

Bioeng Transl Med. 2018 Apr 17;3(2):148-155. doi: 10.1002/btm2.10089. eCollection 2018 May.

11.

Engineering clinical translation-Introduction to Special Issue Dedicated to 2017 Bioengineering and Translational Medicine Conference.

Kannan RM, Mitragotri S.

Bioeng Transl Med. 2018 Jul 27;3(2):73. doi: 10.1002/btm2.10099. eCollection 2018 May. No abstract available.

12.

Transdermal insulin delivery using choline-based ionic liquids (CAGE).

Tanner EEL, Ibsen KN, Mitragotri S.

J Control Release. 2018 Sep 28;286:137-144. doi: 10.1016/j.jconrel.2018.07.029. Epub 2018 Jul 17.

PMID:
30026081
13.

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude.

Brenner JS, Pan DC, Myerson JW, Marcos-Contreras OA, Villa CH, Patel P, Hekierski H, Chatterjee S, Tao JQ, Parhiz H, Bhamidipati K, Uhler TG, Hood ED, Kiseleva RY, Shuvaev VS, Shuvaeva T, Khoshnejad M, Johnston I, Gregory JV, Lahann J, Wang T, Cantu E, Armstead WM, Mitragotri S, Muzykantov V.

Nat Commun. 2018 Jul 11;9(1):2684. doi: 10.1038/s41467-018-05079-7.

14.

Ionic liquids for oral insulin delivery.

Banerjee A, Ibsen K, Brown T, Chen R, Agatemor C, Mitragotri S.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7296-7301. doi: 10.1073/pnas.1722338115. Epub 2018 Jun 25.

15.

Macrophage-mediated delivery of light activated nitric oxide prodrugs with spatial, temporal and concentration control.

Evans MA, Huang PJ, Iwamoto Y, Ibsen KN, Chan EM, Hitomi Y, Ford PC, Mitragotri S.

Chem Sci. 2018 Mar 16;9(15):3729-3741. doi: 10.1039/c8sc00015h. eCollection 2018 Apr 21.

16.

Transdermal immunomodulation: Principles, advances and perspectives.

Zhao Z, Ukidve A, Dasgupta A, Mitragotri S.

Adv Drug Deliv Rev. 2018 Mar 1;127:3-19. doi: 10.1016/j.addr.2018.03.010. Epub 2018 Mar 29. Review.

PMID:
29604373
17.

Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlation.

Vogus DR, Pusuluri A, Chen R, Mitragotri S.

Bioeng Transl Med. 2018 Jan 19;3(1):49-57. doi: 10.1002/btm2.10082. eCollection 2018 Jan.

18.

Ionic liquids for addressing unmet needs in healthcare.

Agatemor C, Ibsen KN, Tanner EEL, Mitragotri S.

Bioeng Transl Med. 2018 Jan 19;3(1):7-25. doi: 10.1002/btm2.10083. eCollection 2018 Jan. Review.

19.

Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells.

Pan DC, Myerson JW, Brenner JS, Patel PN, Anselmo AC, Mitragotri S, Muzykantov V.

Sci Rep. 2018 Jan 25;8(1):1615. doi: 10.1038/s41598-018-19897-8.

20.

Microfluidic co-culture devices to assess penetration of nanoparticles into cancer cell mass.

Jarvis M, Arnold M, Ott J, Pant K, Prabhakarpandian B, Mitragotri S.

Bioeng Transl Med. 2017 Sep 26;2(3):268-277. doi: 10.1002/btm2.10079. eCollection 2017 Sep.

Supplemental Content

Loading ...
Support Center